Published in Prostate on May 15, 2006
Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS One (2011) 1.20
SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation. Mol Cell Biol (2011) 1.19
Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci U S A (2012) 0.95
Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. J Bone Miner Res (2011) 0.91
Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells. Cancer Res (2009) 0.89
Methylation-sensitive regulation of TMS1/ASC by the Ets factor, GA-binding protein-alpha. J Biol Chem (2009) 0.88
Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis (2011) 0.84
DNA methylation and apoptosis resistance in cancer cells. Cells (2013) 0.79
Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin Cancer Res (2010) 0.78
Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure. J Card Fail (2015) 0.77
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells. Oncotarget (2015) 0.75
Inflammasomes in Inflammation-Induced Cancer. Front Immunol (2017) 0.75
Novel role of ASC as a regulator of metastatic phenotype. Cancer Med (2016) 0.75
Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion? Wien Med Wochenschr (2014) 0.75
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 6.04
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer (2007) 3.57
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer. J Pathol (2009) 2.13
Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues. Diagn Mol Pathol (2008) 1.64
Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping. Diagn Mol Pathol (2011) 1.48
Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J Mol Diagn (2007) 1.44
Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. J Mol Diagn (2012) 1.34
Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol (2006) 1.32
Residency training in pathology informatics: a virtual rotation solution. Am J Clin Pathol (2009) 1.23
In vitro transcription amplification and labeling methods contribute to the variability of gene expression profiling with DNA microarrays. J Mol Diagn (2006) 1.14
Clinical genomics of renal epithelial tumors. Cancer Genet (2011) 1.05
Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. J Mol Diagn (2010) 1.02
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate (2011) 1.00
Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression. Diagn Pathol (2012) 0.97
Identification of tissue of origin in body fluid specimens using a gene expression microarray assay. Cancer Cytopathol (2011) 0.91
Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J Neurochem (2002) 0.91
DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS One (2009) 0.91
Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence. Prostate (2008) 0.90
Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol (2012) 0.90
Opposing roles of folate in prostate cancer. Urology (2013) 0.86
A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors. Am J Surg Pathol (2013) 0.85
Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality. Am J Surg Pathol (2009) 0.85
Reproducibility and performance of virtual karyotyping with SNP microarrays for the detection of chromosomal imbalances in formalin-fixed paraffin-embedded tissues. Diagn Mol Pathol (2010) 0.84
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Hum Pathol (2011) 0.84
Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chin J Cancer (2012) 0.83
False negative results from using common PCR reagents. BMC Res Notes (2011) 0.80
p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes. Am J Clin Pathol (2008) 0.80
Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnol Lett (2014) 0.80
Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromes. Leuk Res (2008) 0.80
Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin Cancer Res (2010) 0.78
Attenuated familial adenomatous polyposis: a case report with mixed features and review of genotype-phenotype correlation. Arch Pathol Lab Med (2005) 0.78
Genomic aberrations in salivary duct carcinoma arising in Warthin tumor of parotid gland: DNA microarray and HER2 fluorescence in situ hybridization. Arch Pathol Lab Med (2011) 0.77
Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors. Diagn Pathol (2008) 0.77
Clearing up the confusion over the glutamate carboxypeptidase II gene. Am J Med Genet A (2004) 0.75
Pattern-selection based power analysis and discrimination of low- and high-grade myelodysplastic syndromes study using SNP arrays. PLoS One (2009) 0.75
A tribute to Jeffrey A. Kant, MD, PhD. J Pathol Inform (2012) 0.75
Cytogenomics and gene expression in a case of metachronous bilateral renal cell carcinomas with drop metastasis: Resolving a diagnostic dilemma with molecular technologies. Pathol Int (2013) 0.75